Metraipolis › archive › dc_ec75497d85d7

Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers — Europe PMC PMID:41301714

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41301714
DOI
10.3390/biomedicines13112619
License (as archived)
solo-consultazione
Archived
2026-11-09T01:27:24.958Z
SHA-256 of the archived text
c5ba4eda37ce0765ab77fa99f812cdcd6862f1a240e4d86765c6a29068cec3d5
Stable URL of this page
https://metraipolis.com/documento/dc_ec75497d85d7

How to cite

Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers — Europe PMC PMID:41301714 — Europe PMC (en), https://europepmc.org/article/MED/41301714 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec75497d85d7 (Metraipolis archive dc_ec75497d85d7, sha256 c5ba4eda37ce0765ab77fa99f812cdcd6862f1a240e4d86765c6a29068cec3d5)
BibTeX
@misc{dcec75497d85d7,
  title = {Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers — Europe PMC PMID:41301714},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41301714},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec75497d85d7; sha256 c5ba4eda37ce0765ab77fa99f812cdcd6862f1a240e4d86765c6a29068cec3d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41301714. Agents can read the archived copy with the MCP tool read_document.